European Monitoring Centre for Drugs and Drug Addiction. (2019) Drug precursor developments in the European Union. Luxembourg: Publications Office of the European Union.
| Preview | Title | Contact |
|---|---|---|
|
PDF (Drug precursor developments in the European Union)
603kB | |
|
PDF (An analysis of the costs of dismantling and cleaning up synthetic drug production sites in Belgium and the Netherlands)
- Supplemental Material
822kB |
This paper describes the significant developments that have occurred in the last 5 to 10 years in the field of drug precursors related to synthetic stimulant drugs produced in the EU. This includes describing the ‘pre-precursor’ phenomenon and responses to it, both by the EU and by the drug producers themselves. The developments are complex and of a deeply technical nature. This paper will be of particular interest to forensic chemists, investigators or those involved in drug precursor control.
This is a supporting publication to the 2019 EU Drug Markets Report.
B Substances > CNS stimulants > Amphetamines
B Substances > CNS stimulants > Methamphetamine
B Substances > CNS stimulants > MDMA / Ecstasy
E Concepts in biomedical areas > Pharmacology and toxicology
MM-MO Crime and law > Substance related offence > Drug offence > Illegal production of drugs
MM-MO Crime and law > Substance related offence > Drug offence > Illegal transportation of drugs (smuggling / trafficking)
MM-MO Crime and law > Substance related offence > Drug offence > Illegal distribution of drugs (drug market / dealing)
MP-MR Policy, planning, economics, work and social services > Policy > Policy on substance use > Supply reduction policy
VA Geographic area > Europe
Repository Staff Only: item control page